Gilead Sciences @GileadSciences · 27 Aug 2026
#GileadNews: The U.S. FDA approves first and only single-tablet regimen for the treatment of HIV in adults who are virologically suppressed, including those on complex multi-tablet regimens. Learn more: https://t.co/ZzAqXVm6Qe https://t.co/YvFPdwpYIz
5 264Views
26Likes
7Reposts
2Replies
3Quotes
2Bookmarks
Is that a lot?
3.20×vs this author's median1 647 views is typical
86Percentile for this authorof 7 recent posts
1.92×vs 10K–100K median2 747 views is typical
7.28%Reachviews ÷ followers
0.72%Engagement rateof viewers reacted